Evidence map›Paper›PMID 40613941›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Comparative anti-cancer properties of carene isoforms induced apoptotic cell death in stomach and lung cancer cell lines.

Sri Renukadevi Balusamy, Abdus Samad, Priyanka Singh, Sneha Sunderraj, Mohamed Farouk Elsadek, Nojood Altwaijry, Johan Sukweenadhi, Haribalan Perumalsamy

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sri Renukadevi BalusamyDepartment of Food Science and Biotechnology, Sejong University, Gwangjin-Gu, Seoul, South Korea.
Abdus SamadGraduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-Si, 17104, Republic of Korea.
Priyanka SinghThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kongens Lyngby, Denmark.
Sneha SunderrajDepartment of Medical and Digital Engineering, College of Engineering, Hanyang University, Seoul, 04763, South Korea.
Mohamed Farouk ElsadekDepartment of Biochemistry, College of Science, King Saud University, P.O. 2455, 11451, Riyadh, Saudi Arabia.
Nojood AltwaijryDepartment of Biochemistry, College of Science, King Saud University, P.O. 2455, 11451, Riyadh, Saudi Arabia.
Johan SukweenadhiDepartment of Plant Biotechnology, Faculty of Biotechnology, University of Surabaya, Raya Kalirungkut, Surabaya, 60293, Indonesia. sukwee@staff.ubaya.ac.id.
Haribalan PerumalsamyCenter for Creative Convergence Education, Hanyang University, Seoul, 04763, South Korea. harijai2004@hanyang.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carene isoforms, particularly 3-carene, are naturally occurring bicyclic monoterpenes from Piper nigrum that exhibit promising anti-cancer properties due to their ability to induce apoptosis in malignant cells, but its mechanisms in gastric (AGS) and lung (H727) cancer cells remain unexplored. In this study, we investigated the effects of 3-carene on cell viability, anti-proliferative activity, and apoptosis in AGS and H727 cells treated with varying concentrations using MTT assays, light and fluorescence microscopy, flow cytometry, qRT-PCR, and molecular docking analyses. Pharmacokinetics and dynamics were assessed via ADMET analysis and simulations. Results demonstrated that 3-carene significantly reduced cell viability in both cell lines, with IC

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicApoptosisLung NeoplasmsStomach NeoplasmsCell Line, TumorCell ProliferationCell SurvivalDose-Response Relationship, DrugHumansMolecular Docking SimulationAntineoplastic AgentsAntineoplastic Agents, Phytogenic3-CareneApoptosisCancerCell cycleEssential oils

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.